Notice Number: NOT-MH-18-060
Key Dates
Release Date: October 23, 2018
PAR-18-941
Issued by
National Institute of Mental Health (NIMH)
Purpose
The purpose of this Notice is to extend PAR-18-941, Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional).
Part 1. Overview Information
Key Dates
Currently reads:
Application Due Date(s) November 26, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review February 2019
Advisory Council Review May 2019
Earliest Start Date July 2019
Expiration Date November 27, 2018
Modified to read:
Application Due Date(s) November 26, 2018, and then standard dates by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s) Not Applicable
Scientific Merit Review February 2019 and then standard dates apply
Advisory Council Review May 2019 and then standard dates apply
Earliest Start Date July 2019
Expiration Date September 8, 2021
All other aspects of this FOA remain unchanged.Inquiries
Please direct all inquiries to:
David McMullen, M.D.
National Institute of Mental Health (NIMH)
Telephone: 301-451-0180
Email: david.mcmullen@nih.gov
and Human Services (HHS)
